Approvals/CIMA-AEMPS/OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Eugia Pharma (Malta) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: f0bce66d3539d799
Drug Cima Aemps Name: OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 88574
Holder Company Name: Eugia Pharma (Malta) Limited
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-01-27
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Eugia Pharma (Malta) Limited

OXALIPLATINO

5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 27, 2023

Approval ID

f0bce66d3539d799

Type

Standard